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A surgical approach is the choice in young infants with MTH, who are furthest from 
the time of physiological involution of the thymus, and when the thymus achieves the 
largest relative size, a surgical approach is the choice. Steroid therapy has been 
shown to be ineffective (4, 9, 16, 18‐20). No surgical complications have been re-
ported, and the outcome is excellent. Recurrence has been seen in only one case.
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1 |  CASE REPORT
A 15‐month‐old boy was admitted to the Emergency Room 
with a history of 3 days of fever, cough, and suspected pneu-
monia. In his past history, only a slight decline in appetite was 
reported. Physical examination revealed diminished air entry 
and crackles at the right hemithorax. A chest X‐ray showed a 
large intrathoracic radiopaque thickening occupying the right 
hemithorax (Figure 1). Laboratory tests revealed: leukocyte 
count 16.36 × 109/L (of which 74% lymphocytes), normal 
C‐reactive protein, and normal biochemical profile. He was 
admitted to our pediatric clinic and treated with ceftriaxone 
(80 mg/kg/d) and clarithromycin (15 mg/kg/d). A chest X‐
ray after 5 days of treatment revealed an improvement in the 
thickening of the right lung, but persistence of mediastinal 
enlargement. A chest computerized tomography scan (CT 
scan) was done and showed enlargement of the anterior me-
diastinum, occupied by solid inhomogeneous predominantly 
hypodense hypovascularized tissue, with a total dimension 
of 9.6 × 6 × 10 cm, with left paramedian development with 
minimal imprint on the jugulo‐subclavian confluence and on 
the homolateral anonymous vein. This was associated with 
pleural effusion of a maximum thickness of about 7 mm. The 
thymus was not well recognized (Figure 2).
Abdominal and neck ultrasounds were normal. 
Echocardiography showed minimum pericardial effusion 
but no heart chamber compression by the mediastinal mass. 
Oncologic markers (α‐fetoprotein, vanillylmandelic acid, 
human chorionic gonadotropin, urinary vanillylmandelic 
acid, homovanillic acid and 5‐hydroxic‐indoleacetic acid) 
were negative. Subsequent complete blood count revealed 
an increase in lymphocytosis (81.9% of 21.78 × 109/L 
leukocytes).
A percutaneous biopsy was carried out to exclude malig-
nancy. Fragment analysis was compatible with thymic tissue, 
making the diagnosis of true thymic hyperplasia (TTH).
Because of clinical improvement and radiological stability 
of the size of the mass, the patient was discharged. A steroidal 
therapy (prednisone 2.5 mg/kg/d) was prescribed for 40 days. 
Radiological investigations showed initially minimal change 
in tumor size, but subsequently a rapid increase in dimension 
that reached 10.8 × 11 × 9 cm, with compression of the heart 
chamber and right main bronchus with atelectasis. The child 
underwent surgical excision of the mass via right thoracotomy. 
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The mass weighed 492 g and measured 15 × 11.5 × 5 cm. 
Microscopic finding showed preservation of the normal thy-
mic architecture. Immunohistochemical analysis revealed TTH 
associated with extramedullary myelopoiesis. Postoperative 
recovery was uneventful, and the patient was discharged from 
hospital five days after surgery. Laboratory results (complete 
blood count and inflammatory indices) at 1 month were normal. 
A chest X‐ray 3 months after surgery was normal. At 10 months 
of follow‐up, the child was asymptomatic and showed regular 
growth; no recurrence was detected.
2 |  DISCUSSION AND 
LITERATURE REVIEW
The thymus is a gland situated in the anterior mediastinum, 
embryologically derived from the third and fourth pairs of 
pharyngeal pouches.1-3 Its size varies with age. From a birth 
mean weight of 15 g, the thymus grows in size until puberty 
to a mean weight of 30‐40 g,4,5 and then, it undergoes pro-
gressive atrophy, to no more than 5‐15 g in the elderly.3 In 
early infancy, the thymus reaches its largest relative size, be-
cause its rate of increase is less than the rest of the body in a 
growing child.1,6 After the age of 2 years, the thymic shadow 
is less frequently visible.6
True thymic hyperplasia is a rare but significant pathol-
ogy in pediatric age because of its potentially serious conse-
quences. It is characterized by an increase in size and weight 
of the thymus gland with preservation of normal thymic ar-
chitecture and immunohistochemical appearance, but with-
out an apparent cause.1,3-5 Its etiology remains unclear.7 It 
must be differentiated from other anterior mediastinal masses 
(including thymic lymphoma, thymoma, and germ cell tu-
mors) and from other causes of thymus enlargement (thymus 
lymphofollicular hyperplasia typical of myasthenia gravis3,8,9 
or thymus enlargement after treatment for malignant tumors, 
stress, and steroid therapy).1,5-7,10 Clinical and instrumental 
diagnosis is difficult. Chemical shift magnetic resonance im-
aging is reported to be helpful in differentiating thymic lym-
phoid hyperplasia from thymic neoplasm, but it is not always 
enough.11 Therefore, separating these entities requires fine‐
needle aspiration or biopsy.1-5,10
Massive true thymic hyperplasia (MTH) is a variant of 
TTH. As there are no generally accepted criteria for defin-
ing “massive,” in literature, the following guidelines are 
suggested: (a) the thymus should be greater than the heart 
shadow on posterior‐anterior chest radiograph, (b) it should 
weigh several times the expected weight for the age of the 
patient, and (c) it should represent more than 2% of the body 
mass.1,2,5 About 50 cases of MTH have been recorded.5,10,12 
The majority of cases occur between 1 and 15 years, rarely 
later.5
Clinically, MTH could present with effects of mediastinal 
compression, for instance, respiratory distress, dysphagia or 
airway obstruction, acute or recurrent pulmonary infections, 
or less commonly as an incidental finding.4
Being a rare condition, there are no guidelines on its man-
agement.A review of the literature revealed that most patients 
(80%) were managed surgically with complete excision of the 
mass, with no postoperative complications.4 Some authors re-
ported that a course of steroid therapy could decrease the size 
of an enlarged thymus gland, because of its immunosuppres-
sive effect on T and B lymphocytes that mature in the thymus 
gland particularly in infancy.4,13,16 But in MTH there is no 
F I G U R E  1  Chest X‐ray of the infant at presentation, showing a 
large intrathoracic radiopaque mass occupying the right hemithorax
F I G U R E  2  Chest CT scan showing the large mediastinal mass
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evidence of efficacy; some of these masses do not respond 
or continue to growth after steroid therapy ends, sometimes 
to sizes greater than pretreatment.2,4,13-15,17-21 Both normal 
thymic tissue and lymphomas may show rebound growth 
after the suspension of steroids.4,13,19-21 Furthermore, there 
are no clear indications regarding duration and dosage of the 
corticosteroid. A small number of patients were reported to 
be treated conservatively, mostly for incidental findings, or 
in children with few symptoms and with no acute complica-
tions.4,10 In fact, the rate of atrophy of an MTH is often very 
slow and it could potentially lead to complications such as 
acute airway obstruction.4 This is true especially in infants, 
who are furthest from the time of the physiological involution 
of the thymus and when the thymus has the largest relative 
size.1
In our case, the decision as to the best management was 
not easy to take, because of the few cases described and the 
absence of clear guidelines on therapy. Following confir-
mation of TTH by biopsy, a period with steroid therapy was 
tried. It proved ineffective, with subsequent enlargement of 
the mass. Subsequently, we performed total surgical excision 
of the mass easily and with no complications.
With the aim of analyzing clinical presentation and man-
agement of giant thymic hyperplasia in young infants, we re-
viewed the cases of MTH reported in the literature between 
1976 and March 2018 in children aged <2 years of life, the 
age when the thymus is relatively largest.1,6
A total of 14 cases met the inclusion criteria, and they are 
all reported in Table 1.1-7,12,14,17,18,22,23
Ten out of fourteen (71.4%) were male and four out of 
fourteen (28.6%) female. The median age at onset of symp-
toms was 10.3 months old. Twelve out of fourteen (85.7%) 
patients presented with respiratory symptoms. MTH was dis-
covered incidentally in only one patient. Six out of fourteen 
(42.9%) patients were initially given steroid treatment, with 
no benefits: in one case, the thymus regrew after therapy was 
suspended; in the others five cases, it was ineffective also due 
to significant preoperative shrinkage.
Finally, all patients, including our case, were managed 
surgically. In children aged <2 years of age with MTH, no 
conservative treatment has been reported. No peri‐ or post‐
operative complications have been observed. In our case, the 
giant mass was well‐distinguished from the surrounding tis-
sues and was not infiltrating; it was easily removed.
Thirteen of the fourteen (92.9%) of patients were asymp-
tomatic during follow‐up. Only in one case, a recurrence was 
observed during follow‐up and it was treated successfully 
with a second surgical resection.
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